We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
GeneDx Holdings
WGS
$1.75B
| $2.69M | ﹤0.01% |
41,944
-681
| -2% | -$62.1K |
|
2127
Community Trust Bancorp
CTBI
$1.38B
| $2.68M | ﹤0.01% |
44,097
-20,427
| -32% | -$1.24M |
|
2128
Credit Acceptance
CACC
$6B
| $2.68M | ﹤0.01% |
6,319
-3,639
| -37% | -$1.72M |
|
2129
Upbound Group
UPBD
$1.19B
| $2.68M | ﹤0.01% |
148,218
-366,431
| -71% | -$7.14M |
|
2130
Pangaea Logistics
PANL
$501M
| $2.66M | ﹤0.01% |
376,296
+221,594
| +143% | +$1.75M |
|
2131
Hanmi Financial
HAFC
$943M
| $2.66M | ﹤0.01% |
100,993
+160
| +0.2% | +$4.31K |
|
2132
Astec Industries
ASTE
$1.3B
| $2.66M | ﹤0.01% |
49,419
+2,176
| +5% | +$117K |
|
2133
NewtekOne
NEWT
$417M
| $2.64M | ﹤0.01% |
241,174
-31,617
| -12% | -$401K |
|
2134
Novavax
NVAX
$1.23B
| $2.63M | ﹤0.01% |
323,506
-5,256
| -2% | -$47.6K |
|
2135
Ingles Markets
IMKTA
$1.63B
| $2.63M | ﹤0.01% |
29,270
+171
| +0.6% | +$13.9K |
|
2136
Quanex
NX
$854M
| $2.61M | ﹤0.01% |
145,352
+1,230
| +0.9% | +$23.2K |
|
2137
J&J Snack Foods
JJSF
$1.43B
| $2.61M | ﹤0.01% |
32,929
+198
| +0.6% | +$17.1K |
|
2138
Aehr Test Systems
AEHR
$2.48B
| $2.61M | ﹤0.01% |
70,357
+1,224
| +2% | +$39.2K |
|
|
EFC
2139
Ellington Financial
EFC
$1.68B
| $2.61M | ﹤0.01% |
219,974
+30,237
| +16% | +$385K |
|
2140
OrthoPediatrics
KIDS
$485M
| $2.6M | ﹤0.01% |
163,987
+131,769
| +409% | +$2.3M |
|
2141
LSB Industries
LXU
$881M
| $2.6M | ﹤0.01% |
174,534
+12,921
| +8% | +$147K |
|
|
PVLA
2142
Palvella Therapeutics
PVLA
$1.98B
| $2.6M | ﹤0.01% |
20,834
+1,258
| +6% | +$131K |
|
2143
Gentherm
THRM
$1.31B
| $2.59M | ﹤0.01% |
93,223
-78,895
| -46% | -$2.58M |
|
2144
STAAR Surgical
STAA
$1.16B
| $2.58M | ﹤0.01% |
137,920
-23,080
| -14% | -$441K |
|
|
SILA
2145
DELISTED
Sila Realty Trust
SILA
| $2.57M | ﹤0.01% |
108,654
+538
| +0.5% | +$13.2K |
|
2146
NCR Voyix
VYX
$1.06B
| $2.57M | ﹤0.01% |
406,050
-9,035
| -2% | -$79.7K |
|
|
CIM
2147
Chimera Investment
CIM
$1.05B
| $2.57M | ﹤0.01% |
204,425
+1,658
| +0.8% | +$21.6K |
|
2148
United States Lime & Minerals
USLM
$3.18B
| $2.56M | ﹤0.01% |
19,625
+727
| +4% | +$87.4K |
|
2149
Clarivate
CLVT
$1.3B
| $2.56M | ﹤0.01% |
1,013,071
+35,802
| +4% | +$91.7K |
|
2150
United Parks & Resorts
PRKS
$2.11B
| $2.56M | ﹤0.01% |
78,363
+656
| +0.8% | +$23K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.